Skip to content
Search

Latest Stories

Employers, Govt urged for action to eliminate burnout in healthcare sector

The Royal Pharmaceutical Society (RPS) has urged the government, NHS and employers of various healthcare organisations to take necessary steps to reduce burnout and eliminate all its root causes.

The latest call by the RPS follows a cross-party health and social care committee’s report which highlighted the scale of stress and burnout among health workers including community pharmacy teams.


The King’s Fund’s written submission stated that NHS staff were 50 per cent more likely to experience high levels of work related stress compared with the general working population.

“This was likely to damage their health and affect care quality, and was associated with patient satisfaction, financial performance, absenteeism and organisational performance,” the Health and Social Care Committee report said.

“Poor staff health and wellbeing was also linked with turnover and intention to quit, along with higher levels of patient mortality in the acute sector,” it added.

Chronic excessive workload has been identified as a key factor of burnout and staff shortages were identified as “the most important factor in determining chronic excessive workload”, with shortages of around ‘one in 10 or one in 12 staff’ in the NHS in January 2020, before the pandemic fully hit, the report highlighted.

The committee has also welcomed the additional support provided to health and care staff during the pandemic. However, it has concluded that “such additional support will need to be maintained during the recovery period and beyond to stop further staff from leaving.”

The report highlights many issues around burnout and wellbeing support that “we are already working on through our Workforce Wellbeing campaign, which focuses on preventing the cause of wellbeing problems, improving workplace culture and the importance of getting support with your wellbeing when needed. Show your support for the campaign,” the RPS said, sharing its views on the report.

Commenting on the report, chair of RPS England Professor Claire Anderson said: “This report underlines yet again how urgent it is that healthcare teams get the support they need. It echoes the results of our 2020 Workforce Wellbeing survey, where 89 per cent of respondents scored as being at high risk of burnout. Despite this, pharmacists and pharmacy teams continue to show their dedication to delivering patient care under extremely challenging circumstances.

“The Committee highlights a number of issues we know all play a part in workforce wellbeing, including having the right skill mix and enough staff to manage workload, support from employers and being able to take a break when you need one.

“The report’s findings on the impact of discrimination are really concerning and underline why it’s vital we drive a change in culture across the health service and make the pharmacy profession more inclusive.

“RPS welcomed the additional support available to pharmacy teams via new wellbeing hubs in England and the report rightly calls for this to continue after the pandemic. It’s positive to see the committee recommend that the new Integrated Care Systems should facilitate access to wellbeing support for all health and care staff in their area.

“Addressing the root causes of staff burnout and tackling discrimination will need concerted action from across the health service. Today’s report shows how the Government, NHS, employers and leaders across pharmacy must work together to support staff so they can keep looking after patients.”

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less